SOURCE: Threshold Pharmaceuticals

Threshold Pharmaceuticals

July 11, 2012 07:30 ET

Threshold Pharmaceuticals Announces Presentation and Webcast at JMP Securities Healthcare Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Jul 11, 2012) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Charles Hart, Vice President of Biology at Threshold, is scheduled to present at the JMP Securities Healthcare Conference on Friday, July 13, at 10:30 am Eastern time in New York City.

A live webcast of the presentation will be available under Webcasts in the Investors section of www.thresholdpharm.com. A replay of the presentation will be archived on the site for 30 days.

About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, Threshold is building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit www.thresholdpharm.com.

Contact Information

  • Contact:
    Joel A. Fernandes
    Threshold Pharmaceuticals, Inc.
    650.474.8273
    Email Contact